Search results
Kura Oncology (NASDAQ:KURA) Stock Rating Reaffirmed by HC Wainwright
ETF DAILY NEWS· 6 days agoKura Oncology (NASDAQ:KURA – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at HC Wainwright in a research note issued on Monday, Benzinga reports. HC Wainwright ...
Arthritis linked to blood cancer mutations
Medical Xpress· 7 days agoThe research focused on seronegative rheumatoid arthritis, a sub-type of the more common rheumatoid arthritis (RA), that differs in the inconsistency of...
Coffee Memorial Blood Center seeks platelet donations amid low supply
KAMR Amarillo· 7 days agoOfficials with the Coffee Memorial Blood Center asked community members to donate blood platelets...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 5 days agoSAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the ...
ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest...
KTLA-TV Los Angeles· 5 days agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results ...
Ayala Pharmaceuticals (NASDAQ:ADXS) Earns Sell Rating from Analysts at StockNews.com
ETF DAILY NEWS· 5 days agoStockNews.com initiated coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research note released on Wednesday. The firm issued a sell rating on the stock. Ayala Pharmaceuticals ...
Secondary cancer: Why breast cancer survivors have a higher risk
Medical News Today· 5 days agoThe age of cancer diagnosis appears to affect second cancer risk, especially for women, as does economic status. In it, researchers from the University of Cambridge in England report that women ...
MD Anderson Research Highlights for April 24, 2024
Newswise· 6 days agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These adva
Tiger Aesthetics Medical, LLC Acquires Assets of Sientra, Inc.
Digital Journal· 6 days agoGRC Application Deverra Therapeutics Granted FDA Fast Track Designation for DVX101 (Dilanubicel) for the Treatment of Acute Myeloid & ...
Agilence Wins Stevie(R) Award for Customer Service for Seventh Year in a Row
Digital Journal· 6 days agoGRC Application Deverra Therapeutics Granted FDA Fast Track Designation for DVX101 (Dilanubicel) for the Treatment of Acute Myeloid & ...